Striatal [123I] FP-CIT SPECT demonstrates dopaminergic deficit in a sporadic case of Creutzfeldt-Jakob disease

Acta Neurologica Scandinavica

Volumn 119, Issue 2, 2009, Pages 131-134

  Ragno, M ^a   Scarcella, M G ^a   Cacchio G ^a   Capellari, S ^b   Di Marzio, F ^a   Parchi, P ^b   Trojano, L ^c  

^a 'C and G Mazzoni' Hospital   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Creutzfeldt Jakob syndrome; Dopaminergic activity; Unilateral Parkinsonism

Indexed keywords

DOPAMINE TRANSPORTER; ETIRACETAM; IODINE 123; IOFLUPANE I 123; LORAZEPAM; OXCARBAZEPINE; UNCLASSIFIED DRUG;

AGED; CASE REPORT; CREUTZFELDT JAKOB DISEASE; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; NOTE; PRESYNAPTIC NERVE; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CARBON RADIOISOTOPES; CREUTZFELDT-JAKOB SYNDROME; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; PUTAMEN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 58449100435     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01075.x     Document Type: Note

References (13)

1. Zerr I, Pocchiari M, Collins S et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000 55 : 811 15.
2. Macfarlane RG, Wroe SJ, Collinge J, Yousry TA, Jager HR. Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry 2007 78 : 664 70.
3. Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D. Movement disorders and Creutzfeldt-Jakob disease: a review. Parkinsonism Relat Disord 2006 12 : 65 71.
4. Rees JH, Smith SJ, Kullmann DM, Hirsch NP, Howard RS. Creutzfeldt-Jakob disease presenting as complex partial status epilepticus: a report of two cases. J Neurol Neurosurg Psychiatry 1999 66 : 406 7.
5. Fernandez-Torre JL, Solar DM, Astudillo A, Cereceda R, Acebes A, Calatayud MT. Creutzfeldt-Jakob disease and non-convulsive status epilepticus: a clinical and electroencephalographic follow-up study. Clin Neurophysiol 2004 115 : 316 19.
6. Donmez B, Cakmur R, Men S, Oztura I, Kitis A. Coexistence of movement disorders and epilepsia partialis continua as the initial signs in probable Creutzfeldt-Jakob disease. Mov Disord 2005 20 : 1220 3.
7. Cambier DM, Kantarci K, Worrell GA, Westmoreland BF, Aksamit AJ. Lateralized and focal clinical, EEG, and FLAIR MRI abnormalities in Creutzfeldt-Jakob disease. Clin Neurophysiol 2003 114 : 1724 8.
8. Maltête D, Guyant-Maréchal L, Gérardin E et al. Hemidystonia as initial manifestation of sporadic Creutzfeldt-Jakob disease. Eur J Neurol 2006 13 : 667 8.
9. Marshall V, Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord 2003 18 : 1415 23.
10. Parchi P, Giese A, Capellari S et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999 46 : 224 33.
11. Josephs KA, Tsuboi Y, Dickson DW. Creutzfeldt-Jakob disease presenting as progressive supranuclear palsy. Eur J Neurol 2004 11 : 343 6.
12. Vlaar AM, de Nijs T, Kessels AG et al. Diagnostic value of 123I-iouflupane and 123I-iodobenzamide SPECT scans in 248 patients with Parkinsonian syndromes. Eur Neurol 2008 59 : 258 66.
13. Oppenheim C, Zuber M, Galanaud D et al. Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2004 75 : 1066 9.